Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 24803-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- FAM92A1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated FAM92A1 antibody (Cat. #24803-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references The ARPKD Protein DZIP1L Regulates Ciliary Protein Entry by Modulating the Architecture and Function of Ciliary Transition Fibers.
Mutations in SCNM1 cause orofaciodigital syndrome due to minor intron splicing defects affecting primary cilia.
Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma.
BAR Domain-Containing FAM92 Proteins Interact with Chibby1 To Facilitate Ciliogenesis.
Chen H, Wu Z, Yan Z, Chen C, Zhang Y, Wang Q, Gao Y, Ling K, Hu J, Wei Q
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Jun;11(24):e2308820
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Jun;11(24):e2308820
Mutations in SCNM1 cause orofaciodigital syndrome due to minor intron splicing defects affecting primary cilia.
Iturrate A, Rivera-Barahona A, Flores CL, Otaify GA, Elhossini R, Perez-Sanz ML, Nevado J, Tenorio-Castano J, Triviño JC, Garcia-Gonzalo FR, Piceci-Sparascio F, De Luca A, Martínez L, Kalaycı T, Lapunzina P, Altunoglu U, Aglan M, Abdalla E, Ruiz-Perez VL
American journal of human genetics 2022 Oct 6;109(10):1828-1849
American journal of human genetics 2022 Oct 6;109(10):1828-1849
Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma.
Guo XR, Wu MY, Dai LJ, Huang Y, Shan MY, Ma SN, Wang J, Peng H, Ding Y, Zhang QF, Tang JM, Ruan XZ, Li DS
Journal of experimental & clinical cancer research : CR 2019 Sep 6;38(1):394
Journal of experimental & clinical cancer research : CR 2019 Sep 6;38(1):394
BAR Domain-Containing FAM92 Proteins Interact with Chibby1 To Facilitate Ciliogenesis.
Li FQ, Chen X, Fisher C, Siller SS, Zelikman K, Kuriyama R, Takemaru KI
Molecular and cellular biology 2016 Nov 1;36(21):2668-2680
Molecular and cellular biology 2016 Nov 1;36(21):2668-2680
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 24803-1-AP( FAM92A1 Antibody) at dilution of 1:600
- Other comments
- WB
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP Result of anti-FAM92A1 (IP:24803-1-AP, 3ug; Detection:24803-1-AP 1:500) with HeLa cells lysate 2000ug.
- Other comments
- IP
Supportive validation
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The FAM92A1 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human FAM92A1. This antibody recognizes human antigen. The FAM92A1 antibody has been validated for the following applications: ELISA, IHC, IP, WB analysis.
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemistry of paraffin-embedded human renal cell carcinoma tissue slide using 24803-1-AP( FAM92A1 Antibody) at dilution of 1:50 (under 10x lens)
- Other comments
- IHC
